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background: High mobility group box 1 (HMGB1) is a multifunctional protein that is included in diverse inflammatory mechanisms in which it can 
induce immune responses. The interaction with RAGE (receptor for advanced glycation end products) can result in inflammatory and autoimmune 
disease. Therefore the aim of this study was to analyze the innate danger signal HMGB1 and its binding partner RAGE on the development of 
autoimmune myocarditis.
Methods: Six weeks old A/J wild type- mice (wt) and A/J-RAGE knockout mice (ko) were immunized with murine cardiac Troponin I (TnI) or control 
buffer in supplemented complete Freund’s adjuvant (CFA). We evaluated in vivo mechanical parameters of cardiac function and collected blood to 
measure the concentration of Troponin T (TnT), HMGB1 and autoantibody titers against TnI. Furthermore, histopathological evaluation, myocardial 
gene and protein expression were assessed.
results: TnI immunized wt-mice (wt/TnI) developed severe inflammation of the myocardium followed by cardiomegaly, fibrosis and reduced 
ejection fraction (EF) compared to control immunized animals (wt/CFA). TnI immunization led to increased HMGB1-levels in blood serum (wt/TnI: 36 
± 5 vs. wt/CFA: 19 ± 7 ng/ml) which correlated with increased protein levels in myocardium. Immunohistological examination of the heart revealed 
HMGB1 positive mononuclear cells. In contrast there was almost no inflammation and fibrosis in RAGE-deficient mice immunized with TnI (ko/TnI) 
(myocarditis score: ko/TnI: 0.4 ± 0.1 vs. wt/TnI: 1.5 ± 0.3, p<0.005). TnI immunized ko-mice showed also significantly lower autoantibodies against 
TnI and reduced TnT levels in serum compared to TnI immunized wt-mice. Furthermore immunized ko- mice displayed preserved cardiac function in 
contrast to immunized littermate controls (EF: ko/TnI: 87 ± 1 vs. wt/TnI: 74 ± 2 %, p<0.0001).
conclusion: Our study suggests that HMGB1 and its main receptor RAGE are important components in the pathogenesis of TnI induced 
autoimmune myocarditis. Both proteins have a key role in inflammatory mechanisms and blockage of one of these molecules might represent a 
novel therapeutic strategy in the treatment of inflammatory cardiomyopathy. 
